AI assistant
Sending…
NRX Pharmaceuticals, Inc. — Director's Dealing 2017
Dec 5, 2017
34346_dirs_2017-12-04_669f364f-eb2c-4684-88da-a81982faf9b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Big Rock Partners Acquisition Corp. (BRPAU)
CIK: 0001719406
Period of Report: 2017-11-20
Reporting Person: Wittman Lori (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 0 | Indirect |
Footnotes
F1: Ms. Wittman does not beneficially own any securities of the issuer. However, Ms. Wittman has a pecuniary interest in securities of the issuer through her ownership of membership interests of Big Rock Partners Sponsor, LLC. Ms. Wittman disclaims beneficial ownership of such securities, except to the extent of her pecuniary interests.
More from NRX Pharmaceuticals, Inc.
Capital/Financing Update
2026
Jun 4
Share Issue/Capital Change
2026
Jun 3
Capital/Financing Update
2026
Jun 2
Capital/Financing Update
2026
Jun 2
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Mar 23
Regulatory Filings
2026
Feb 27
Annual Report
2026
Feb 23
Proxy Solicitation & Information Statement
2026
Feb 23
Regulatory Filings
2026
Feb 17